Identification of a Papain-Like Protease Inhibitor with Potential for Repurposing in Combination with an Mpro Protease Inhibitor for Treatment of SARS-CoV-2. (2022). Archives of Clinical and Biomedical Research, 6(6), 993-1002. https://fortunejournals.org/ojs/index.php/acbr/article/view/14979